|
|
ApoImmune, Inc. is a biotechnology company committed to the development of powerful new therapeutics to treat chronic and acute life-threatening diseases and improve patients' quality of life. ApoImmune is founded on a broad-platform protein-based technology used for immunomodulation, that is, using one's own immune system to treat disease. ApoImmune uses its unprecedented technology platform to enable the safe and selective targeting of a wide array of therapeutics to any specified cell without introducing foreign genetic material into the patient. The molecular architecture of ApoImmune's proprietary therapeutics enables signal amplification at the cell surface, resulting in a much more robust biological response than that produced by other more conventional approaches. <more>
|
|
